SlideShare a Scribd company logo
CHOLINERGICS, ANTICHOLINERGICS
& ANTICHOLINESTERASES
Part 2: Cholinergics & anticholinesterases
Mr. Somdatta Y Chaudhari
Dept. of Pharm. Chemistry
P.E.S. Modern College of Pharmacy, Nigdi
P.E.S. Modern College of Pharmacy, Nigdi 1
Contents
Part 2: Cholinergics & anticholinesterases
12. Cholinergic Antagonists (Muscarinic receptor) (2 slides)
12.1. Atropine
12.2. Hyoscine (scopolamine)
12.3. Comparison of atropine with acetylcholine
12.4. Analogues of atropine
12.5. Simplified Analogues (2 slides)
12.6. SAR for Antagonists (3 slides)
12.7. Binding Site for Antagonists (2 slides)
13. Cholinergic Antagonists (Nicotinic receptor)
13.1. Curare (2 slides)
13.2. Binding
13.3. Analogues of tubocurarine (5 slides)
P.E.S. Modern College of Pharmacy, Nigdi 2
12. Cholinergic Antagonists (Muscarinic receptor)
• Drugs which bind to cholinergic receptor but do not activate it
• Prevent acetylcholine from binding
• Opposite clinical effect to agonists - lower activity of
acetylcholine
Postsynaptic
nerve
Ach
Antagonist
Ach
Postsynaptic
nerve
Ach
P.E.S. Modern College of Pharmacy, Nigdi 3
12. Cholinergic Antagonists (Muscarinic receptor)
Clinical Effects
• Decrease of saliva and gastric secretions
• Relaxation of smooth muscle
• Decrease in motility of GIT and urinary tract
• Dilation of pupils
Uses
• Shutting down digestion for surgery
• Ophthalmic examinations
• Relief of peptic ulcers
• Treatment of Parkinson’s Disease
• Anticholinesterase poisoning
• Motion sickness
P.E.S. Modern College of Pharmacy, Nigdi 4
12.1 Atropine
• Racemic form of hyoscyamine
• Source - roots of belladonna (1831) (deadly nightshade)
• Used as a poison
• Used as a medicine
decreases GIT motility
antidote for anticholinesterase poisoning
dilation of eye pupils
• CNS side effects – hallucinations
*
N
H
O
C
O
Me
CH
CH2OH
easily racemised
12. Cholinergic Antagonists (Muscarinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 5
• Opthalmic use of atropine a as mydriatic (dilating) agent
has been largely replaced by use of analogs tropicamide
and cyclopenatolate (vida infra).
• However, atropine, and its chiral analog hyoscyamine,
are utilized to treat gastrointestinal disorders
• Also these antagonists can be used to treat the symptoms
of an excess of acetylcholine, such as might occur upon
exposure to an inhibitor of the enzyme acetylcholinesterase
(such as a nerve gas).P.E.S. Modern College of Pharmacy, Nigdi 6
• Atropine is also used to avoid bradycardia (too slow heart rate) during some
procedures (such as pediatric RSI, rapid sequence intubation), which also use
succinylcholine (suxamethonium chloride) as a neuromuscular blocking agent
(antagonist at the nicotinic Ach receptors).
• As shown in the diagram above, the atropine serves as an antagonist of acetycholine
at the M2 receptor of the sinoatrial node.
• The acetylcholine at this junction triggers a GPCR using the Gi G-protein, normally
leading to decrease in the levels of cAMP. Thus the atropine restores normal levels of
cAMP, reversing the effects of vagus nerve stimulation.
P.E.S. Modern College of Pharmacy, Nigdi 7
12.2 Hyoscine (scopolamine)
• Source - thorn apple
• Medical use - treatment of motion sickness
• Used as a truth drug (CNS effects)
*
N
H
O
C
O
Me
CH
CH2OHO
H
H
12. Cholinergic Antagonists (Muscarinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 8
Hyoscine (Scopolamine)
P.E.S. Modern College of Pharmacy, Nigdi 9
12.3 Comparison of atropine with acetylcholine
• Relative positions of ester and nitrogen similar in both molecules
• Nitrogen in atropine is ionised
• Amine and ester are important binding groups (ionic + H-bonds)
• Aromatic ring of atropine is an extra binding group (vdW)
• Atropine binds with a different induced fit - no activation
• Atropine binds more strongly than acetylcholine
N
O
C
O
Me
H
CH
CH2OH
C
O
O CH3
NMe3
CH2CH2
12. Cholinergic Antagonists (Muscarinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 10
12.4 Analogues of atropine
• Analogues are fully ionised
• Analogues unable to cross the blood brain barrier
• No CNS side effects
Atropine methonitrate
(lowers GIT motility)
N
H
O
C
O
CH3
CH
CH2OH
H3C
NO3
Ipratropium
(bronchodilator & anti-asthmatic)
N
H
O
C
O
CH(CH3)2
CH
CH2OH
H3C
Br
12. Cholinergic Antagonists (Muscarinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 11
The combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and
salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD)
and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations
under the trade name Combivent.
Medications commonly used in asthma and COPD (primarily R03) edit
Anticholinergics: Ipratropium, Tiotropium
Short acting β2-agonists: Salbutamol, Terbutaline
Long acting β2-agonists (LABA): Bambuterol, Clenbuterol, Fenoterol, Formoterol, Salmeterol
Corticosteroids: Beclometasone, Budesonide, Ciclesonide, Fluticasone
Leukotriene antagonists: Montelukast, Pranlukast, Zafirlukast
Xanthines: Aminophylline, Theobromine, Theophylline
Mast cell stabilizers: Cromoglicate, Nedocromil
Combination products: Budesonide/formoterol, Fluticasone/salmeterol, Ipratropium/salbutamol
P.E.S. Modern College of Pharmacy, Nigdi 12
12.5 Simplified Analogues
Pharmacophore = ester + basic amine + aromatic ring
Amprotropine
N
CH2
CH2
CH2
O
C
O
Et
CH
CH2OH
Et
Tridihexethyl bromide
HO C CH2CH2N(Et)3 Br
Propantheline chloride
Cl
O C
O
O CH2CH2 N
CH
Me
CH
Me Me
Me
Me
12. Cholinergic Antagonists (Muscarinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 13
12.5 Simplified Analogues
Tropicamide
(opthalmics)
Cyclopentolate
(opthalmics)
Benztropine
(Parkinsons disease)
Benzhexol
(Parkinsons disease)
Pirenzepine
(anti-ulcer)
CH
CH2OH
O
N
CH2CH3
N
N
H
O
CH
Me
N
CH
N N
CHN
C O
CH2
N
N
O
Me
12. Cholinergic Antagonists (Muscarinic receptor)
CH
O
O
OH
Me2N
P.E.S. Modern College of Pharmacy, Nigdi 14
Tropicamide
Cyclopentolate
• Tropicamide and Cyclopentolate (above) are among the most
commonly employed mydriatic (dilating) and cycloplegic
(paralyzing) agents
• Both function as antagonists at the muscarinic acetylcholine
receptors P.E.S. Modern College of Pharmacy, Nigdi 15
12.6 SAR for Antagonists
Important features
• Tertiary amine (ionised) or a quaternary nitrogen
• Aromatic ring
• Ester
• N-Alkyl groups (R) can be larger than methyl (unlike agonists)
• Large branched acyl group
• R’ = aromatic or heteroaromatic ring
• Branching of aromatic/heteroaromatic rings is important
R2N
CH2
CH2
O
C
O
CH
R'
R'
R' = Aromatic or
Heteroaromatic
12. Cholinergic Antagonists (Muscarinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 16
InactiveActive
Cl
O C
O
O CH2CH2 N
CH
Me
CH
Me Me
Me
Me CH2
C
O
O CH2CH2NR2
12.6 SAR for Antagonists
12. Cholinergic Antagonists (Muscarinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 17
Tertiary amine (ionised)
or quaternary nitrogen
Aromatic ring
Ester
N-Alkyl groups (R) can be
larger than methyl
R’ = aromatic or heteroaromatic
Branching of Ar rings important
Quaternary nitrogen
Aromatic ring
Ester
N-Alkyl groups = methyl
R’ = H
SAR for Antagonists SAR for Agonists
12.6 SAR for Antagonists vs. Agonists
12. Cholinergic Antagonists (Muscarinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 18
RECEPTOR SURFACE
Acetylcholine
binding site
12.7 Binding Site for Antagonists
van der Waals
binding regions
for antagonists
12. Cholinergic Antagonists (Muscarinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 19
12.7 Binding Site for Antagonists
CH
Me
Me
CH
MeMe
N
Me
CH2CH2O
C
O
O
Cl
H2N Asn
CO2
CH2
CH2
O
O
C
NMeR2
O
12. Cholinergic Antagonists (Muscarinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 20
13. Cholinergic Antagonists (Nicotinic receptor)
13.1 Curare
• Extract from ourari plant
• Used for poison arrows
• Causes paralysis (blocks acetylcholine signals to muscles)
• Active principle = tubocurarine
Tubocurarine
N
HO
MeO
O
CH2
OMe
N
Me
Me
H
O
Me
CH2
OH
H
H
P.E.S. Modern College of Pharmacy, Nigdi 21
Tubocurarine chloride is a competitive antagonist of nicotinic neuromuscular
acetylcholine receptors, It is one of the chemicals that can be obtained from curare,
itself an extract of Chondodendron tomentosum, a plant found in South American
jungles which is used as a source of arrow poison. Native indians hunting animals
with this poison were able to eat the animal's contaminated flesh without being
affected by the toxin because tubocurarine cannot easily cross mucous
membranes and is thus inactive orally.
P.E.S. Modern College of Pharmacy, Nigdi 22
• Tubocurarine began to be
clinically utilized as a surgical
neuromuscular blocking agent in
the 1940’s
• This drug has been supplanted
by safer medicines, but is still
utilized as part of the lethal
injection procedure.
P.E.S. Modern College of Pharmacy, Nigdi 23
13. Cholinergic Antagonists (Nicotinic receptor)
Pharmacophore
• Two quaternary centres at specific separation (1.15nm)
• Different mechanism of action from atropine based antagonists
• Different binding interactions
Clinical uses
• Neuromuscular blocker for surgical operations
• Permits lower and safer levels of general anaesthetic
• Tubocurarine used as neuromuscular blocker but side effects
P.E.S. Modern College of Pharmacy, Nigdi 24
13.2 Binding
a) Receptor dimer
S
b) Interaction with tubocurarine
protein complex
(5 subunits)
diameter=8nm
8nm
9-10nm
N N
N N Tubocurarine
Acetylcholine binding site
13. Cholinergic Antagonists (Nicotinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 25
13.3 Analogues of tubocurarine
• Long lasting
• Long recovery times
• Side effects on heart
• No longer in clinical use
Decamethonium
Me3N(CH2)10NMe3
13. Cholinergic Antagonists (Nicotinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 26
Suxamethonium
(Succinylcholine)
Me3NCH2CH2 O
C
O
CH2
C
O
O CH2CH2NMe3CH2
• Esters incorporated
• Shorter lifetime (5 min)
• Fast onset and short duration
• Frequently used during intubation
• Side effects at autonomic ganglia
P.E.S. Modern College of Pharmacy, Nigdi 27
13.3 Analogues of tubocurarine
• Steroid acts as a spacer for the quaternary centres (1.09nm)
• Acyl groups are added to introduce the Ach skeleton
• Faster onset then tubocurarine but slower than suxamethonium
• Longer duration of action than suxamethonium (45 min)
• No effect on blood pressure and fewer side effects
13. Cholinergic Antagonists (Nicotinic receptor)
Pancuronium (R=Me)
Vecuronium (R=H)
Me
O
NMe
N
O
Me
Me
Me
O
O
H
H H
H
P.E.S. Modern College of Pharmacy, Nigdi 28
• Pancuronium is used to block the neuromuscular junction during
surgery or intubation.
• In the US, pancuronium (pavulon) is the second of three drugs used
in execution by lethal injection
• Lawsuits against the lethal injection procedure have charged that
this drug would make the patient unable to cry out if he was in pain, as
might occur if insufficient sodium thiopentol (the anesthetic) had been
administered P.E.S. Modern College of Pharmacy, Nigdi 29
13.3 Analogues of tubocurarine
• Design based on tubocurarine and suxamethonium
• Lacks cardiac side effects
• Rapidly broken down in blood both chemically and metabolically
• Avoids patient variation in metabolic enzymes
• Lifetime is 30 minutes
• Administered as an i.v. drip
• Self destruct system limits lifetime
Atracurium
N
CH2 CH2
C
O
O
MeO
OMe
H
N
(CH2)5MeO O
C
OMe
O
CH2 CH2
Me
MeO
OMe
OMe
OMe
13. Cholinergic Antagonists (Nicotinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 30
13.3 Analogues of tubocurarine
Atracurium stable at acid pH
Hofmann elimination at blood pH (7.4)
N
Me
CH2
Ph
CH C
H
O
R
ACTIVE
-H
CHH2C C
O
Ph
R
N
Me
INACTIVE
13. Cholinergic Antagonists (Nicotinic receptor)
P.E.S. Modern College of Pharmacy, Nigdi 31
• An improved version of atracurium is the purified form of just one of the ten
possible stereoisomers, that has the highest efficacy and least side effects
• The name of the blocking agent is cisatracurium (NIMBEX)
• This is the most widely used agent surgically.
• 80% of the drug is metabolized via Hofmann elimination, thus lowering variability
in patients with possible liver or renal disease.
• The Hofmann degradation is only dependent on the pH and temperature of the
plasma.
P.E.S. Modern College of Pharmacy, Nigdi 32
13.3 Analogues of tubocurarine
Mivacurium
• Faster onset (2 min)
• Shorter duration (15 min)
13. Cholinergic Antagonists (Nicotinic receptor)
N
MeO
OMe
H3C
NMeO
OMe
Me
MeO
OMe
OMe
OMe
O
O
O
O
P.E.S. Modern College of Pharmacy, Nigdi 33
• The use of mivacurium has declined in recent years, in
favor of other agents with better overall profile.
P.E.S. Modern College of Pharmacy, Nigdi 34

More Related Content

What's hot

Cholinergictransmissionanddrugs 150225023103-conversion-gate01 kk
Cholinergictransmissionanddrugs 150225023103-conversion-gate01 kkCholinergictransmissionanddrugs 150225023103-conversion-gate01 kk
Cholinergictransmissionanddrugs 150225023103-conversion-gate01 kk
KishanKumar253
 
Acetylcholinesterase inhibitors : Dr Rahul Kunkulol
Acetylcholinesterase inhibitors : Dr Rahul KunkulolAcetylcholinesterase inhibitors : Dr Rahul Kunkulol
Acetylcholinesterase inhibitors : Dr Rahul Kunkulol
Rahul Kunkulol
 
OPIOID ANALGESICS
OPIOID ANALGESICSOPIOID ANALGESICS
Cholinergic system and drugs
Cholinergic system and drugs Cholinergic system and drugs
Cholinergic system and drugs
Karun Kumar
 
Sevoflurane in neuroanaesthesia
Sevoflurane in neuroanaesthesiaSevoflurane in neuroanaesthesia
Sevoflurane in neuroanaesthesia
narasimha reddy
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
shayanfatima
 
Anticholinergic agent
Anticholinergic agentAnticholinergic agent
Anticholinergic agent
ASHOK GAUTAM
 
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
kencha swathi
 
Induction agents
Induction agentsInduction agents
Induction agents
Shreyas Kate
 
Feline emergencies organophosphate toxicity
Feline emergencies   organophosphate toxicityFeline emergencies   organophosphate toxicity
Feline emergencies organophosphate toxicity
Guillaume Michigan
 
Anaphylaxis
AnaphylaxisAnaphylaxis
Anaphylaxis
Geetanjali Verma
 
Endocrine system
Endocrine systemEndocrine system
Endocrine system
Mirza Anwar Baig
 
screening of ans drugs
screening of ans drugsscreening of ans drugs
screening of ans drugs
Srota Dawn
 
Screening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-convertedScreening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-converted
B V V S Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
shashikanthsothuku
 
Vinayak atropine glyco
Vinayak atropine glycoVinayak atropine glyco
Vinayak atropine glyco
dr anurag giri
 
Dextromethorphan antagonizes acute 5HT depletion by PCA
Dextromethorphan antagonizes acute 5HT depletion by PCADextromethorphan antagonizes acute 5HT depletion by PCA
Dextromethorphan antagonizes acute 5HT depletion by PCA
Mark Henderson, Ph.D.
 
Adrenergic & cholinergic agents
Adrenergic & cholinergic agentsAdrenergic & cholinergic agents
Adrenergic & cholinergic agents
AkshayYadav176
 
Anti cholinergics
Anti cholinergicsAnti cholinergics
Anti cholinergics
Rajib Karmakar
 
Drugs Acting on Cholinergic System 1
Drugs Acting on Cholinergic System 1Drugs Acting on Cholinergic System 1
Drugs Acting on Cholinergic System 1
Pravin Prasad
 

What's hot (20)

Cholinergictransmissionanddrugs 150225023103-conversion-gate01 kk
Cholinergictransmissionanddrugs 150225023103-conversion-gate01 kkCholinergictransmissionanddrugs 150225023103-conversion-gate01 kk
Cholinergictransmissionanddrugs 150225023103-conversion-gate01 kk
 
Acetylcholinesterase inhibitors : Dr Rahul Kunkulol
Acetylcholinesterase inhibitors : Dr Rahul KunkulolAcetylcholinesterase inhibitors : Dr Rahul Kunkulol
Acetylcholinesterase inhibitors : Dr Rahul Kunkulol
 
OPIOID ANALGESICS
OPIOID ANALGESICSOPIOID ANALGESICS
OPIOID ANALGESICS
 
Cholinergic system and drugs
Cholinergic system and drugs Cholinergic system and drugs
Cholinergic system and drugs
 
Sevoflurane in neuroanaesthesia
Sevoflurane in neuroanaesthesiaSevoflurane in neuroanaesthesia
Sevoflurane in neuroanaesthesia
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
 
Anticholinergic agent
Anticholinergic agentAnticholinergic agent
Anticholinergic agent
 
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
 
Induction agents
Induction agentsInduction agents
Induction agents
 
Feline emergencies organophosphate toxicity
Feline emergencies   organophosphate toxicityFeline emergencies   organophosphate toxicity
Feline emergencies organophosphate toxicity
 
Anaphylaxis
AnaphylaxisAnaphylaxis
Anaphylaxis
 
Endocrine system
Endocrine systemEndocrine system
Endocrine system
 
screening of ans drugs
screening of ans drugsscreening of ans drugs
screening of ans drugs
 
Screening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-convertedScreening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-converted
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
Vinayak atropine glyco
Vinayak atropine glycoVinayak atropine glyco
Vinayak atropine glyco
 
Dextromethorphan antagonizes acute 5HT depletion by PCA
Dextromethorphan antagonizes acute 5HT depletion by PCADextromethorphan antagonizes acute 5HT depletion by PCA
Dextromethorphan antagonizes acute 5HT depletion by PCA
 
Adrenergic & cholinergic agents
Adrenergic & cholinergic agentsAdrenergic & cholinergic agents
Adrenergic & cholinergic agents
 
Anti cholinergics
Anti cholinergicsAnti cholinergics
Anti cholinergics
 
Drugs Acting on Cholinergic System 1
Drugs Acting on Cholinergic System 1Drugs Acting on Cholinergic System 1
Drugs Acting on Cholinergic System 1
 

Similar to Drugs acting on parasympathetic nervous system2

Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
KumudMendhe
 
Part II: UNIT cholinergic neurotransmitter - Antagonist Drugs
Part II: UNIT cholinergic neurotransmitter - Antagonist DrugsPart II: UNIT cholinergic neurotransmitter - Antagonist Drugs
Part II: UNIT cholinergic neurotransmitter - Antagonist Drugs
SONALI PAWAR
 
2 Pharmacology I, intro ANS cholinergic drugs.pptx
2 Pharmacology I,  intro ANS  cholinergic drugs.pptx2 Pharmacology I,  intro ANS  cholinergic drugs.pptx
2 Pharmacology I, intro ANS cholinergic drugs.pptx
Ahmad Kharousheh
 
Cholinergic+antagonists+by+pharma+raptors
Cholinergic+antagonists+by+pharma+raptorsCholinergic+antagonists+by+pharma+raptors
Cholinergic+antagonists+by+pharma+raptors
Aniket Kale
 
Anticholinergics Kampala international university.pptx
Anticholinergics Kampala international university.pptxAnticholinergics Kampala international university.pptx
Anticholinergics Kampala international university.pptx
YIKIISAAC
 
Cholinergic blockers and evapouraton facts
Cholinergic blockers and evapouraton factsCholinergic blockers and evapouraton facts
Cholinergic blockers and evapouraton facts
YashThorat20
 
Anti cholinergics-1, aimst
Anti cholinergics-1, aimstAnti cholinergics-1, aimst
Anti cholinergics-1, aimst
BADAR UDDIN UMAR
 
antimuscarnic drug
antimuscarnic drugantimuscarnic drug
antimuscarnic drug
Islam Home
 
Cholinergic antagonists and blockers-Dr.Jibachha Sah,M.V.Sc,Lecturer
Cholinergic antagonists and blockers-Dr.Jibachha Sah,M.V.Sc,LecturerCholinergic antagonists and blockers-Dr.Jibachha Sah,M.V.Sc,Lecturer
Cholinergic antagonists and blockers-Dr.Jibachha Sah,M.V.Sc,Lecturer
Dr. Jibachha Sah
 
Parasympathomimetic Agents Direct Acting with SAR & Cholinesters Reactivation
Parasympathomimetic Agents Direct Acting with SAR & Cholinesters Reactivation Parasympathomimetic Agents Direct Acting with SAR & Cholinesters Reactivation
Parasympathomimetic Agents Direct Acting with SAR & Cholinesters Reactivation
TejasSuruse
 
Drugs Acting on Autonomic Nervous System
Drugs Acting on Autonomic Nervous SystemDrugs Acting on Autonomic Nervous System
Drugs Acting on Autonomic Nervous System
Abhijeet Lokras
 
28_ANS_Pharmacology (Sakhile).pptx
28_ANS_Pharmacology (Sakhile).pptx28_ANS_Pharmacology (Sakhile).pptx
28_ANS_Pharmacology (Sakhile).pptx
Sakhile Ndlalane
 
Cholinergic transmission and drugs
Cholinergic transmission and  drugsCholinergic transmission and  drugs
Cholinergic transmission and drugs
dr sanjay dhawale
 
IVTh sem anticholinergics-converted unit-3.pptx
IVTh sem anticholinergics-converted unit-3.pptxIVTh sem anticholinergics-converted unit-3.pptx
IVTh sem anticholinergics-converted unit-3.pptx
UnitedGroupofInstitu1
 
cholinergics and anticholinergics presentation.pptx
cholinergics and anticholinergics presentation.pptxcholinergics and anticholinergics presentation.pptx
cholinergics and anticholinergics presentation.pptx
NoorSalam17
 
advmedchem_lecture8_9.ppt
advmedchem_lecture8_9.pptadvmedchem_lecture8_9.ppt
advmedchem_lecture8_9.ppt
Vicky570089
 
advmedchem_lecture8_9.ppt
advmedchem_lecture8_9.pptadvmedchem_lecture8_9.ppt
advmedchem_lecture8_9.ppt
NasimMohammadi8
 
advmedchem_lecture8_9.ppt
advmedchem_lecture8_9.pptadvmedchem_lecture8_9.ppt
advmedchem_lecture8_9.ppt
NasimMohammadi8
 
Adrenergic Drugs II
Adrenergic Drugs IIAdrenergic Drugs II
Adrenergic Drugs II
coolboy101pk
 
Sar of choinergic &; anticholinergic drugs
Sar of choinergic &; anticholinergic drugsSar of choinergic &; anticholinergic drugs
Sar of choinergic &; anticholinergic drugs
SURABHI PHARMACY COLLEGE
 

Similar to Drugs acting on parasympathetic nervous system2 (20)

Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
 
Part II: UNIT cholinergic neurotransmitter - Antagonist Drugs
Part II: UNIT cholinergic neurotransmitter - Antagonist DrugsPart II: UNIT cholinergic neurotransmitter - Antagonist Drugs
Part II: UNIT cholinergic neurotransmitter - Antagonist Drugs
 
2 Pharmacology I, intro ANS cholinergic drugs.pptx
2 Pharmacology I,  intro ANS  cholinergic drugs.pptx2 Pharmacology I,  intro ANS  cholinergic drugs.pptx
2 Pharmacology I, intro ANS cholinergic drugs.pptx
 
Cholinergic+antagonists+by+pharma+raptors
Cholinergic+antagonists+by+pharma+raptorsCholinergic+antagonists+by+pharma+raptors
Cholinergic+antagonists+by+pharma+raptors
 
Anticholinergics Kampala international university.pptx
Anticholinergics Kampala international university.pptxAnticholinergics Kampala international university.pptx
Anticholinergics Kampala international university.pptx
 
Cholinergic blockers and evapouraton facts
Cholinergic blockers and evapouraton factsCholinergic blockers and evapouraton facts
Cholinergic blockers and evapouraton facts
 
Anti cholinergics-1, aimst
Anti cholinergics-1, aimstAnti cholinergics-1, aimst
Anti cholinergics-1, aimst
 
antimuscarnic drug
antimuscarnic drugantimuscarnic drug
antimuscarnic drug
 
Cholinergic antagonists and blockers-Dr.Jibachha Sah,M.V.Sc,Lecturer
Cholinergic antagonists and blockers-Dr.Jibachha Sah,M.V.Sc,LecturerCholinergic antagonists and blockers-Dr.Jibachha Sah,M.V.Sc,Lecturer
Cholinergic antagonists and blockers-Dr.Jibachha Sah,M.V.Sc,Lecturer
 
Parasympathomimetic Agents Direct Acting with SAR & Cholinesters Reactivation
Parasympathomimetic Agents Direct Acting with SAR & Cholinesters Reactivation Parasympathomimetic Agents Direct Acting with SAR & Cholinesters Reactivation
Parasympathomimetic Agents Direct Acting with SAR & Cholinesters Reactivation
 
Drugs Acting on Autonomic Nervous System
Drugs Acting on Autonomic Nervous SystemDrugs Acting on Autonomic Nervous System
Drugs Acting on Autonomic Nervous System
 
28_ANS_Pharmacology (Sakhile).pptx
28_ANS_Pharmacology (Sakhile).pptx28_ANS_Pharmacology (Sakhile).pptx
28_ANS_Pharmacology (Sakhile).pptx
 
Cholinergic transmission and drugs
Cholinergic transmission and  drugsCholinergic transmission and  drugs
Cholinergic transmission and drugs
 
IVTh sem anticholinergics-converted unit-3.pptx
IVTh sem anticholinergics-converted unit-3.pptxIVTh sem anticholinergics-converted unit-3.pptx
IVTh sem anticholinergics-converted unit-3.pptx
 
cholinergics and anticholinergics presentation.pptx
cholinergics and anticholinergics presentation.pptxcholinergics and anticholinergics presentation.pptx
cholinergics and anticholinergics presentation.pptx
 
advmedchem_lecture8_9.ppt
advmedchem_lecture8_9.pptadvmedchem_lecture8_9.ppt
advmedchem_lecture8_9.ppt
 
advmedchem_lecture8_9.ppt
advmedchem_lecture8_9.pptadvmedchem_lecture8_9.ppt
advmedchem_lecture8_9.ppt
 
advmedchem_lecture8_9.ppt
advmedchem_lecture8_9.pptadvmedchem_lecture8_9.ppt
advmedchem_lecture8_9.ppt
 
Adrenergic Drugs II
Adrenergic Drugs IIAdrenergic Drugs II
Adrenergic Drugs II
 
Sar of choinergic &; anticholinergic drugs
Sar of choinergic &; anticholinergic drugsSar of choinergic &; anticholinergic drugs
Sar of choinergic &; anticholinergic drugs
 

More from Somu Chaudhari

PHARMACY.pdf
PHARMACY.pdfPHARMACY.pdf
PHARMACY.pdf
Somu Chaudhari
 
Circular 104-2021.pdf
Circular 104-2021.pdfCircular 104-2021.pdf
Circular 104-2021.pdf
Somu Chaudhari
 
Democracy, Election and Governance Syllabus_03.072020.pdf
Democracy, Election  and Governance Syllabus_03.072020.pdfDemocracy, Election  and Governance Syllabus_03.072020.pdf
Democracy, Election and Governance Syllabus_03.072020.pdf
Somu Chaudhari
 
Paripatrak No - 2 (2022)_08022022.pdf
Paripatrak No - 2 (2022)_08022022.pdfParipatrak No - 2 (2022)_08022022.pdf
Paripatrak No - 2 (2022)_08022022.pdf
Somu Chaudhari
 
Exam S & T 962 Dated 21.04.2022.pdf
Exam S & T 962 Dated 21.04.2022.pdfExam S & T 962 Dated 21.04.2022.pdf
Exam S & T 962 Dated 21.04.2022.pdf
Somu Chaudhari
 
PCI syllabus for F. Y. B.Pharm orientation
PCI syllabus for F. Y. B.Pharm orientationPCI syllabus for F. Y. B.Pharm orientation
PCI syllabus for F. Y. B.Pharm orientation
Somu Chaudhari
 

More from Somu Chaudhari (6)

PHARMACY.pdf
PHARMACY.pdfPHARMACY.pdf
PHARMACY.pdf
 
Circular 104-2021.pdf
Circular 104-2021.pdfCircular 104-2021.pdf
Circular 104-2021.pdf
 
Democracy, Election and Governance Syllabus_03.072020.pdf
Democracy, Election  and Governance Syllabus_03.072020.pdfDemocracy, Election  and Governance Syllabus_03.072020.pdf
Democracy, Election and Governance Syllabus_03.072020.pdf
 
Paripatrak No - 2 (2022)_08022022.pdf
Paripatrak No - 2 (2022)_08022022.pdfParipatrak No - 2 (2022)_08022022.pdf
Paripatrak No - 2 (2022)_08022022.pdf
 
Exam S & T 962 Dated 21.04.2022.pdf
Exam S & T 962 Dated 21.04.2022.pdfExam S & T 962 Dated 21.04.2022.pdf
Exam S & T 962 Dated 21.04.2022.pdf
 
PCI syllabus for F. Y. B.Pharm orientation
PCI syllabus for F. Y. B.Pharm orientationPCI syllabus for F. Y. B.Pharm orientation
PCI syllabus for F. Y. B.Pharm orientation
 

Recently uploaded

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 

Recently uploaded (20)

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 

Drugs acting on parasympathetic nervous system2

  • 1. CHOLINERGICS, ANTICHOLINERGICS & ANTICHOLINESTERASES Part 2: Cholinergics & anticholinesterases Mr. Somdatta Y Chaudhari Dept. of Pharm. Chemistry P.E.S. Modern College of Pharmacy, Nigdi P.E.S. Modern College of Pharmacy, Nigdi 1
  • 2. Contents Part 2: Cholinergics & anticholinesterases 12. Cholinergic Antagonists (Muscarinic receptor) (2 slides) 12.1. Atropine 12.2. Hyoscine (scopolamine) 12.3. Comparison of atropine with acetylcholine 12.4. Analogues of atropine 12.5. Simplified Analogues (2 slides) 12.6. SAR for Antagonists (3 slides) 12.7. Binding Site for Antagonists (2 slides) 13. Cholinergic Antagonists (Nicotinic receptor) 13.1. Curare (2 slides) 13.2. Binding 13.3. Analogues of tubocurarine (5 slides) P.E.S. Modern College of Pharmacy, Nigdi 2
  • 3. 12. Cholinergic Antagonists (Muscarinic receptor) • Drugs which bind to cholinergic receptor but do not activate it • Prevent acetylcholine from binding • Opposite clinical effect to agonists - lower activity of acetylcholine Postsynaptic nerve Ach Antagonist Ach Postsynaptic nerve Ach P.E.S. Modern College of Pharmacy, Nigdi 3
  • 4. 12. Cholinergic Antagonists (Muscarinic receptor) Clinical Effects • Decrease of saliva and gastric secretions • Relaxation of smooth muscle • Decrease in motility of GIT and urinary tract • Dilation of pupils Uses • Shutting down digestion for surgery • Ophthalmic examinations • Relief of peptic ulcers • Treatment of Parkinson’s Disease • Anticholinesterase poisoning • Motion sickness P.E.S. Modern College of Pharmacy, Nigdi 4
  • 5. 12.1 Atropine • Racemic form of hyoscyamine • Source - roots of belladonna (1831) (deadly nightshade) • Used as a poison • Used as a medicine decreases GIT motility antidote for anticholinesterase poisoning dilation of eye pupils • CNS side effects – hallucinations * N H O C O Me CH CH2OH easily racemised 12. Cholinergic Antagonists (Muscarinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 5
  • 6. • Opthalmic use of atropine a as mydriatic (dilating) agent has been largely replaced by use of analogs tropicamide and cyclopenatolate (vida infra). • However, atropine, and its chiral analog hyoscyamine, are utilized to treat gastrointestinal disorders • Also these antagonists can be used to treat the symptoms of an excess of acetylcholine, such as might occur upon exposure to an inhibitor of the enzyme acetylcholinesterase (such as a nerve gas).P.E.S. Modern College of Pharmacy, Nigdi 6
  • 7. • Atropine is also used to avoid bradycardia (too slow heart rate) during some procedures (such as pediatric RSI, rapid sequence intubation), which also use succinylcholine (suxamethonium chloride) as a neuromuscular blocking agent (antagonist at the nicotinic Ach receptors). • As shown in the diagram above, the atropine serves as an antagonist of acetycholine at the M2 receptor of the sinoatrial node. • The acetylcholine at this junction triggers a GPCR using the Gi G-protein, normally leading to decrease in the levels of cAMP. Thus the atropine restores normal levels of cAMP, reversing the effects of vagus nerve stimulation. P.E.S. Modern College of Pharmacy, Nigdi 7
  • 8. 12.2 Hyoscine (scopolamine) • Source - thorn apple • Medical use - treatment of motion sickness • Used as a truth drug (CNS effects) * N H O C O Me CH CH2OHO H H 12. Cholinergic Antagonists (Muscarinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 8
  • 9. Hyoscine (Scopolamine) P.E.S. Modern College of Pharmacy, Nigdi 9
  • 10. 12.3 Comparison of atropine with acetylcholine • Relative positions of ester and nitrogen similar in both molecules • Nitrogen in atropine is ionised • Amine and ester are important binding groups (ionic + H-bonds) • Aromatic ring of atropine is an extra binding group (vdW) • Atropine binds with a different induced fit - no activation • Atropine binds more strongly than acetylcholine N O C O Me H CH CH2OH C O O CH3 NMe3 CH2CH2 12. Cholinergic Antagonists (Muscarinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 10
  • 11. 12.4 Analogues of atropine • Analogues are fully ionised • Analogues unable to cross the blood brain barrier • No CNS side effects Atropine methonitrate (lowers GIT motility) N H O C O CH3 CH CH2OH H3C NO3 Ipratropium (bronchodilator & anti-asthmatic) N H O C O CH(CH3)2 CH CH2OH H3C Br 12. Cholinergic Antagonists (Muscarinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 11
  • 12. The combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent. Medications commonly used in asthma and COPD (primarily R03) edit Anticholinergics: Ipratropium, Tiotropium Short acting β2-agonists: Salbutamol, Terbutaline Long acting β2-agonists (LABA): Bambuterol, Clenbuterol, Fenoterol, Formoterol, Salmeterol Corticosteroids: Beclometasone, Budesonide, Ciclesonide, Fluticasone Leukotriene antagonists: Montelukast, Pranlukast, Zafirlukast Xanthines: Aminophylline, Theobromine, Theophylline Mast cell stabilizers: Cromoglicate, Nedocromil Combination products: Budesonide/formoterol, Fluticasone/salmeterol, Ipratropium/salbutamol P.E.S. Modern College of Pharmacy, Nigdi 12
  • 13. 12.5 Simplified Analogues Pharmacophore = ester + basic amine + aromatic ring Amprotropine N CH2 CH2 CH2 O C O Et CH CH2OH Et Tridihexethyl bromide HO C CH2CH2N(Et)3 Br Propantheline chloride Cl O C O O CH2CH2 N CH Me CH Me Me Me Me 12. Cholinergic Antagonists (Muscarinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 13
  • 14. 12.5 Simplified Analogues Tropicamide (opthalmics) Cyclopentolate (opthalmics) Benztropine (Parkinsons disease) Benzhexol (Parkinsons disease) Pirenzepine (anti-ulcer) CH CH2OH O N CH2CH3 N N H O CH Me N CH N N CHN C O CH2 N N O Me 12. Cholinergic Antagonists (Muscarinic receptor) CH O O OH Me2N P.E.S. Modern College of Pharmacy, Nigdi 14
  • 15. Tropicamide Cyclopentolate • Tropicamide and Cyclopentolate (above) are among the most commonly employed mydriatic (dilating) and cycloplegic (paralyzing) agents • Both function as antagonists at the muscarinic acetylcholine receptors P.E.S. Modern College of Pharmacy, Nigdi 15
  • 16. 12.6 SAR for Antagonists Important features • Tertiary amine (ionised) or a quaternary nitrogen • Aromatic ring • Ester • N-Alkyl groups (R) can be larger than methyl (unlike agonists) • Large branched acyl group • R’ = aromatic or heteroaromatic ring • Branching of aromatic/heteroaromatic rings is important R2N CH2 CH2 O C O CH R' R' R' = Aromatic or Heteroaromatic 12. Cholinergic Antagonists (Muscarinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 16
  • 17. InactiveActive Cl O C O O CH2CH2 N CH Me CH Me Me Me Me CH2 C O O CH2CH2NR2 12.6 SAR for Antagonists 12. Cholinergic Antagonists (Muscarinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 17
  • 18. Tertiary amine (ionised) or quaternary nitrogen Aromatic ring Ester N-Alkyl groups (R) can be larger than methyl R’ = aromatic or heteroaromatic Branching of Ar rings important Quaternary nitrogen Aromatic ring Ester N-Alkyl groups = methyl R’ = H SAR for Antagonists SAR for Agonists 12.6 SAR for Antagonists vs. Agonists 12. Cholinergic Antagonists (Muscarinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 18
  • 19. RECEPTOR SURFACE Acetylcholine binding site 12.7 Binding Site for Antagonists van der Waals binding regions for antagonists 12. Cholinergic Antagonists (Muscarinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 19
  • 20. 12.7 Binding Site for Antagonists CH Me Me CH MeMe N Me CH2CH2O C O O Cl H2N Asn CO2 CH2 CH2 O O C NMeR2 O 12. Cholinergic Antagonists (Muscarinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 20
  • 21. 13. Cholinergic Antagonists (Nicotinic receptor) 13.1 Curare • Extract from ourari plant • Used for poison arrows • Causes paralysis (blocks acetylcholine signals to muscles) • Active principle = tubocurarine Tubocurarine N HO MeO O CH2 OMe N Me Me H O Me CH2 OH H H P.E.S. Modern College of Pharmacy, Nigdi 21
  • 22. Tubocurarine chloride is a competitive antagonist of nicotinic neuromuscular acetylcholine receptors, It is one of the chemicals that can be obtained from curare, itself an extract of Chondodendron tomentosum, a plant found in South American jungles which is used as a source of arrow poison. Native indians hunting animals with this poison were able to eat the animal's contaminated flesh without being affected by the toxin because tubocurarine cannot easily cross mucous membranes and is thus inactive orally. P.E.S. Modern College of Pharmacy, Nigdi 22
  • 23. • Tubocurarine began to be clinically utilized as a surgical neuromuscular blocking agent in the 1940’s • This drug has been supplanted by safer medicines, but is still utilized as part of the lethal injection procedure. P.E.S. Modern College of Pharmacy, Nigdi 23
  • 24. 13. Cholinergic Antagonists (Nicotinic receptor) Pharmacophore • Two quaternary centres at specific separation (1.15nm) • Different mechanism of action from atropine based antagonists • Different binding interactions Clinical uses • Neuromuscular blocker for surgical operations • Permits lower and safer levels of general anaesthetic • Tubocurarine used as neuromuscular blocker but side effects P.E.S. Modern College of Pharmacy, Nigdi 24
  • 25. 13.2 Binding a) Receptor dimer S b) Interaction with tubocurarine protein complex (5 subunits) diameter=8nm 8nm 9-10nm N N N N Tubocurarine Acetylcholine binding site 13. Cholinergic Antagonists (Nicotinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 25
  • 26. 13.3 Analogues of tubocurarine • Long lasting • Long recovery times • Side effects on heart • No longer in clinical use Decamethonium Me3N(CH2)10NMe3 13. Cholinergic Antagonists (Nicotinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 26
  • 27. Suxamethonium (Succinylcholine) Me3NCH2CH2 O C O CH2 C O O CH2CH2NMe3CH2 • Esters incorporated • Shorter lifetime (5 min) • Fast onset and short duration • Frequently used during intubation • Side effects at autonomic ganglia P.E.S. Modern College of Pharmacy, Nigdi 27
  • 28. 13.3 Analogues of tubocurarine • Steroid acts as a spacer for the quaternary centres (1.09nm) • Acyl groups are added to introduce the Ach skeleton • Faster onset then tubocurarine but slower than suxamethonium • Longer duration of action than suxamethonium (45 min) • No effect on blood pressure and fewer side effects 13. Cholinergic Antagonists (Nicotinic receptor) Pancuronium (R=Me) Vecuronium (R=H) Me O NMe N O Me Me Me O O H H H H P.E.S. Modern College of Pharmacy, Nigdi 28
  • 29. • Pancuronium is used to block the neuromuscular junction during surgery or intubation. • In the US, pancuronium (pavulon) is the second of three drugs used in execution by lethal injection • Lawsuits against the lethal injection procedure have charged that this drug would make the patient unable to cry out if he was in pain, as might occur if insufficient sodium thiopentol (the anesthetic) had been administered P.E.S. Modern College of Pharmacy, Nigdi 29
  • 30. 13.3 Analogues of tubocurarine • Design based on tubocurarine and suxamethonium • Lacks cardiac side effects • Rapidly broken down in blood both chemically and metabolically • Avoids patient variation in metabolic enzymes • Lifetime is 30 minutes • Administered as an i.v. drip • Self destruct system limits lifetime Atracurium N CH2 CH2 C O O MeO OMe H N (CH2)5MeO O C OMe O CH2 CH2 Me MeO OMe OMe OMe 13. Cholinergic Antagonists (Nicotinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 30
  • 31. 13.3 Analogues of tubocurarine Atracurium stable at acid pH Hofmann elimination at blood pH (7.4) N Me CH2 Ph CH C H O R ACTIVE -H CHH2C C O Ph R N Me INACTIVE 13. Cholinergic Antagonists (Nicotinic receptor) P.E.S. Modern College of Pharmacy, Nigdi 31
  • 32. • An improved version of atracurium is the purified form of just one of the ten possible stereoisomers, that has the highest efficacy and least side effects • The name of the blocking agent is cisatracurium (NIMBEX) • This is the most widely used agent surgically. • 80% of the drug is metabolized via Hofmann elimination, thus lowering variability in patients with possible liver or renal disease. • The Hofmann degradation is only dependent on the pH and temperature of the plasma. P.E.S. Modern College of Pharmacy, Nigdi 32
  • 33. 13.3 Analogues of tubocurarine Mivacurium • Faster onset (2 min) • Shorter duration (15 min) 13. Cholinergic Antagonists (Nicotinic receptor) N MeO OMe H3C NMeO OMe Me MeO OMe OMe OMe O O O O P.E.S. Modern College of Pharmacy, Nigdi 33
  • 34. • The use of mivacurium has declined in recent years, in favor of other agents with better overall profile. P.E.S. Modern College of Pharmacy, Nigdi 34